Polaris Partners Leads USD27m Series A+ for Singapore’s Engine Biosciences
Source(s): Deal Street Asia
Polaris Partners led a USD27m Series A+ for Singapore-based biotech company Engine Biosciences, with participation from Coronet Ventures, SEEDS Capital, as well as follow-on from Temasek-backed ClavystBio, Invus and EDBI.